weight loss glp 1 pill 6 Things to Know About the New GLP-1 No injections The next phase of the

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)

This means food stays in your stomach longer, keeping you physically full

That wider menu matters because some patients are not just comparing price

The most common side effects include nausea, constipation, diarrhea, bloating, reflux, fatigue, and decreased appetite

Heres what you can do to stay safe: 1

Recently, in a phase 1 clinical study, AMG133 demonstrated a pronounced dose-dependent weight loss in participants with obesity